pt141 peptide information PT-141 (Bremelanotide) PT-141 Peptide | Bremelanotide |

101 Despite progress, clinical translation of nanozyme-based AP therapy is hindered by limited preclinical models and passive delivery, long-term biosafety concerns (metal ion leaching), and challenges in scalable manufacturing

Chronic high glucose (25 mM) induces endoplasmic reticulum (ER) stress characterized by activation of the PKR-like endoplasmic reticulum kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2)/C/EBP homologous protein (CHOP) axis, increased ROS accumulation, upregulation of pro-apoptotic BCL2 associated X apoptosis regulator (Bax) and Bcl-2-associated death promoter (Bad), caspase-3 cleavage, and enhanced apoptosis

10.1038/s41598-021-99025-1 Sci

doi:10.1007/s12603-013-0023-x Saruhan E, Sertoglu E, Unal Y, Bek S, Kutlu G

The validated in silico structural model therefore indicates that the SAM-key domain would contact a part of the ATPase domain that is known to facilitate regulation of catalytic activity in nucleosome remodelers (Szerlong et al, 2008